Disease/Infection News

RSS

New study suggests broad neutralizing antibody could provide three years of COVID protection

In a recent article published in the journal Science Translational Medicine, researchers showed that a novel, lab-engineered monoclonal antibody (mAb), adintrevimab conferred up to 50% protection against symptomatic coronavirus disease 2019 (COVID-19). Furthermore, it demonstrated this exceptional efficacy in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–naïve individuals even at titers as low as 1:30.

27 Mar 2023

How can Europe tackle its unfinished tuberculosis business?

A recent Eurosurveillance journal editorial discussed the progress in the EU/EEA, between 2018 and 2021, towards achieving the 2030 targets for TB elimination.

27 Mar 2023

On current trajectory, Euro region will not achieve sustainable development goals for tuberculosis reduction

A recent study assessed the progress toward the Sustainable Development Goals (SDG) targets for tuberculosis (TB) elimination.

27 Mar 2023

Epigenome reprogramming after SARS-CoV-2 infection

Researchers performed a 3D evaluation of SARS-CoV-2 infected human cells.

27 Mar 2023

COVID-19 infant hospitalizations reduced by a 3rd maternal vaccine dose during pregnancy

Researchers investigated the effects of the booster coronavirus disease 2019 (COVID-19) vaccine during pregnancy on COVID-19-related hospitalization rates among infants.

27 Mar 2023

Despite raising LDL levels, coffee lowers systolic and diastolic blood pressure

Researchers performed a cross-sectional analysis of the general population of Hamburg City, Germany.

27 Mar 2023

How did the prevalence of autism spectrum disorders change before and during COVID-19?

Researchers reported on autism spectrum disorders prevalence among four-year-old children.

27 Mar 2023

Estimating the risk of contact transmission of COVID-19 for indoor environments

While COVID-19 can be transmitted via contact with contaminated objects, most studies have focused on airborne droplet transmission.

27 Mar 2023

UQ researchers lead new study on bacteria that cause sepsis

University of Queensland researchers have led a national study on the four main bacteria that cause sepsis, providing new targets for developing antibiotics.

27 Mar 2023

Combination of hydrocortisone and fludrocortisone benefits patients with septic shock

Sepsis occurs in approximately 1.7 million hospitalizations in the U.S. with in more than a third of hospitalizations resulting in death.

27 Mar 2023

Myeloid cells can harbor HIV in people taking antiretroviral therapy

A subset of white blood cells, known as myeloid cells, can harbor HIV in people who have been virally suppressed for years on antiretroviral therapy, according to findings from a small study supported by the National Institutes of Health.

27 Mar 2023

Demographic, geographic, and temporal variables associated with C. auris cases in Italy

A recent study reported growing cases of Candida auris in North Italy.

27 Mar 2023

Study reveals new insights into how different countries' research establishments respond to disease

In a new study, researchers examined how a country's number of published 3D protein structures for coronaviruses, including the one responsible for COVID-19, correlated with its economic output and population.

27 Mar 2023

Study adds valuable new information on the treatment of COVID-19

Although steroid treatment for COVID-19 is reportedly beneficial in some cases, details—such as the upper dosing limits and safety of this method—have not yet been clarified.

27 Mar 2023

Monocytes may be a stable reservoir of HIV in patients taking antiretroviral therapy

To develop treatments that may one day entirely rid the body of HIV infection, scientists have long sought to identify all of the places that the virus can hide its genetic code.

27 Mar 2023

Researchers discuss strategic actions to stimulate research on fungal diseases in the context of the WHO fungal pathogens priority list

Researchers in the US and Brazil explored priority fungal pathogens recognized by the WHO.

27 Mar 2023

Disease/Infection News

New study suggests broad neutralizing antibody could provide three years of COVID protection

How can Europe tackle its unfinished tuberculosis business?

On current trajectory, Euro region will not achieve sustainable development goals for tuberculosis reduction

Epigenome reprogramming after SARS-CoV-2 infection

COVID-19 infant hospitalizations reduced by a 3rd maternal vaccine dose during pregnancy

Despite raising LDL levels, coffee lowers systolic and diastolic blood pressure

How did the prevalence of autism spectrum disorders change before and during COVID-19?

Estimating the risk of contact transmission of COVID-19 for indoor environments

UQ researchers lead new study on bacteria that cause sepsis

Combination of hydrocortisone and fludrocortisone benefits patients with septic shock

Myeloid cells can harbor HIV in people taking antiretroviral therapy

Demographic, geographic, and temporal variables associated with C. auris cases in Italy

Study reveals new insights into how different countries' research establishments respond to disease

Study adds valuable new information on the treatment of COVID-19

Monocytes may be a stable reservoir of HIV in patients taking antiretroviral therapy

Researchers discuss strategic actions to stimulate research on fungal diseases in the context of the WHO fungal pathogens priority list

How can microbiota be used to make wine more health beneficial?

SARS-CoV-2 reinfection uncommon among individuals with evidence of previous infection during the pre-vaccine era

Possible pathways of C. auris emergence and the hypothetical role of interspecies transmission

Researchers isolate an IgM exhibiting ultrapotent neutralization from a Zika virus-infected pregnant woman

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Latest News